Issue 2, 2021

The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs

Abstract

Covering: 2000 up to 2020

Few classes of natural products have inspired as many chemists and biologists as have the iboga alkaloids. This family of monoterpenoid indole alkaloids includes the anti-addictive compound ibogaine as well as catharanthine, a precursor to the chemotherapeutic vinblastine. Despite being known for over 120 years, these small molecules continue to challenge our assumptions about biosynthetic pathways, catalyze our creativity for constructing complex architectures, and embolden new approaches for treating mental illness. This review will cover recent advances in both the biosynthesis and chemical synthesis of iboga alkaloids as well as their use as next-generation neurotherapeutics. Whenever appropriate, we provide historical context for the discoveries of the past decade and indicate areas that have yet to be resolved. While significant progress regarding their chemistry and pharmacology has been made since the 1960s, it is clear that the iboga alkaloids will continue to stoke scientific innovation for years to come.

Graphical abstract: The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs

Supplementary files

Article information

Article type
Review Article
Submitted
05 Jun 2020
First published
14 Aug 2020

Nat. Prod. Rep., 2021,38, 307-329

The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs

R. N. Iyer, D. Favela, G. Zhang and D. E. Olson, Nat. Prod. Rep., 2021, 38, 307 DOI: 10.1039/D0NP00033G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements